ARGX

argenx (ARGX)

About argenx (ARGX)

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Details

Daily high

$832.90

Daily low

$811.00

Price at open

$815.04

52 Week High

$934.62

52 Week Low

$510.06

Market cap

50.8B

Dividend yield

0.00%

Volume

276,407

Avg. volume

405,831

P/E ratio

38.53

argenx News